Inventor · disambiguated record
Grant Raymond Wickman
Also filed as: WICKMAN GRANT · WICKMAN GRANT RAYMOND
13 granted patents·9 pending applications·78 citations·filing 2006–2025
90Inventor score
Top patents by PatentIndex Score
22 records- 0196US10000576B1Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2018·Granted Jun 19, 2018·23 cites·30 claims
- 0293US7537762B2Human monoclonal antibodies to activin receptor-like kinase-1AMGEN FREMONT INC·Filed 2006·Granted May 26, 2009·34 cites·15 claims
- 0390US2025122305A1Bispecific antigen binding constructs targeting her2ZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 0489US11325981B2Bispecific antigen-binding constructs targeting Her2ZYMEWORKS INC·Filed 2018·Granted May 10, 2022·2 cites·19 claims
- 0589US10947319B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2014·Granted Mar 16, 2021·5 cites·18 claims
- 0682US8039596B2Alpha 5-beta 1 antibodies and their usesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 18, 2011·4 cites·10 claims
- 0781US12215166B2Bispecific antigen binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2022·Granted Feb 4, 2025·0 cites·23 claims
- 0881US2025084184A1Methods of using bispecific antigen-binding constructs targeting her2ZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 0976US11965036B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2021·Granted Apr 23, 2024·0 cites·19 claims
- 1073US10273303B2Monovalent antigen binding constructs targeting EGFR and/or HER2 and uses thereofZYMEWORKS INC·Filed 2014·Granted Apr 30, 2019·2 cites·21 claims
- 1173US10239951B2Bispecific HER2 and HER3 antigen binding constructsZYMEWORKS INC·Filed 2014·Granted Mar 26, 2019·2 cites·20 claims
- 1272US8080646B2Human monoclonal antibodies to activin receptor-like kinase-1NORTH MICHAEL AIDAN·Filed 2009·Granted Dec 20, 2011·3 cites·43 claims
- 1371US9221915B2Human monoclonal antibodies to activin receptor-like kinase-1BELOUSKI SHELLEY SIMS·Filed 2011·Granted Dec 29, 2015·3 cites·26 claims
- 1466US12157775B2Methods of using bispecific antigen-binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2020·Granted Dec 3, 2024·0 cites·23 claims
- 1561US2021269553A1Methods using monovalent antigen binding constructs targeting her2ZYMEWORKS INC·Filed 2020·Application pending·0 cites
- 1654US2014154268A1Alpha5-beta1 antibodies and their usesPFIZER·Filed 2013·Application pending·0 cites
- 1753US2017355779A1Methods of using bispecific antigen-binding constructs targeting her2ZYMEWORKS INC·Filed 2015·Application pending·0 cites
- 1852US2016297891A1Methods using monovalent antigen binding constructs targeting her2ZYMEWORKS INC·Filed 2014·Application pending·0 cites
- 1949US8399647B2Alpha5-beta1 antibodies and their usesBENDER STEVEN L·Filed 2011·Granted Mar 19, 2013·0 cites·8 claims
- 2046US2023265202A1Antibody constructs binding 4-1bb and folate receptor alpha and uses thereofZYMEWORKS INC·Filed 2021·Application pending·0 cites
- 2143US2025235548A1Antibody-drug conjugates targeting napi2b and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 2242US2025277030A1Anti-napi2b antibodies and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Grant Raymond Wickman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →